4th Cytokine-Based Drug Development Summit 2023

Kongressthemen
New doors open for Cytokine drug developers to treat diseases both in and beyond oncology with novel masking and tissue targeting mechanisms and the abundance of preclinical and clinical efficacy data as more companies get additional funding to boost their pipelines.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/1561164-3?pid=4832

Speakers: Alexandra Wolfarth, Senior Scientist, NeoImmuneTech Inc., Angus Sinclair, SVP Immuno-oncology Research, IGM Biosciences, and more

https://go.evvnt.com/1561164-2?pid=4832

Herr Hanson Wade